Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,411 | 1,245 | 1,327 | 0 | 1,203 |
| Cost of Goods | 1,053 | 1,117 | 1,112 | N/A | 1,151 |
| Gross Profit | 357 | 128 | 216 | N/A | 53 |
| Operating Expenses | 1,104 | -1,000 | 1,196 | 0 | 1,294 |
| Operating Income | -693 | -635 | -869 | N/A | -1,090 |
| Interest Expense | 175 | 14 | 5 | 0 | 6 |
| Other Income | -162 | 649 | 1 | 0 | 2 |
| Pre-tax Income | -1,030 | 0 | -872 | 0 | -1,095 |
| Net Income Continuous | -1,030 | N/A | -872 | N/A | -1,095 |
| Net Income | $-1,030 | $N/A | $-872 | $N/A | $-1,095 |
| EPS Basic Total Ops | -0.40 | -0.10 | -0.40 | N/A | -0.50 |
| EPS Basic Continuous Ops | -0.40 | N/A | -0.38 | N/A | -0.48 |
| EPS Diluted Total Ops | -0.40 | -0.10 | -0.40 | N/A | -0.50 |
| EPS Diluted Continuous Ops | -0.40 | N/A | -0.38 | N/A | -0.48 |
| EBITDA(a) | $223 | $1,501 | $-869 | $N/A | $-297 |